Showing results (151-160 of 163) with videos related to
Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth SuppressionChuandong Geng, Man-Chao Zhang, Ganiraju C Manyam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate CancerWei Zhang, Bo Liu, Wenhui Wu, et al.Molecular Cancer Therapeutics|June 23, 2021
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate CancerCheng Wu, Shan Peng, Patrick G Pilié, et al.Cancer Research|October 10, 2014
Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanomaY N Vashisht Gopal, Helen Rizos, Guo Chen, et al.Nature Sustainability|November 20, 2018
The environmental costs and benefits of high-yield farmingAndrew Balmford, Tatsuya Amano, Harriet Bartlett, et al.Biological Reviews of the Cambridge Philosophical Society|July 7, 2021
Post COVID-19: a solution scan of options for preventing future zoonotic epidemicsSilviu O Petrovan, David C Aldridge, Harriet Bartlett, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2020
Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified SettingJeffrey S Morris, Rajyalakshmi Luthra, Yusha Liu, et al.Science Signaling|May 25, 2017
Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancerLikun Li, Styliani Karanika, Guang Yang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2020
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy DevelopmentNallasivam Palanisamy, Jun Yang, Peter D A Shepherd, et al.Nature Communications|May 30, 2014
A pan-cancer proteomic perspective on The Cancer Genome AtlasRehan Akbani, Patrick Kwok Shing Ng, Henrica M J Werner, et al.Pageof 17